191 related articles for article (PubMed ID: 23418928)
21. OX40 (CD134) expression in sentinel lymph nodes correlates with prognostic features of primary melanomas.
Sarff M; Edwards D; Dhungel B; Wegmann KW; Corless C; Weinberg AD; Vetto JT
Am J Surg; 2008 May; 195(5):621-5; discussion 625. PubMed ID: 18374895
[TBL] [Abstract][Full Text] [Related]
22. The number of lymph nodes involved with metastatic disease does not affect outcome in melanoma patients as long as all disease is confined to the sentinel lymph node.
Jakub JW; Huebner M; Shivers S; Nobo C; Puleo C; Harmsen WS; Reintgen DS
Ann Surg Oncol; 2009 Aug; 16(8):2245-51. PubMed ID: 19517194
[TBL] [Abstract][Full Text] [Related]
23. The numbers of FoxP3+ lymphocytes in sentinel lymph nodes of breast cancer patients correlate with primary tumor size but not nodal status.
Gupta R; Babb JS; Singh B; Chiriboga L; Liebes L; Adams S; Demaria S
Cancer Invest; 2011 Jul; 29(6):419-25. PubMed ID: 21649468
[TBL] [Abstract][Full Text] [Related]
24. Intradermal CpG-B activates both plasmacytoid and myeloid dendritic cells in the sentinel lymph node of melanoma patients.
Molenkamp BG; van Leeuwen PA; Meijer S; Sluijter BJ; Wijnands PG; Baars A; van den Eertwegh AJ; Scheper RJ; de Gruijl TD
Clin Cancer Res; 2007 May; 13(10):2961-9. PubMed ID: 17504997
[TBL] [Abstract][Full Text] [Related]
25. Local delivery of CpG-B and GM-CSF induces concerted activation of effector and regulatory T cells in the human melanoma sentinel lymph node.
van den Hout MF; Sluijter BJ; Santegoets SJ; van Leeuwen PA; van den Tol MP; van den Eertwegh AJ; Scheper RJ; de Gruijl TD
Cancer Immunol Immunother; 2016 Apr; 65(4):405-15. PubMed ID: 26935057
[TBL] [Abstract][Full Text] [Related]
26. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma.
Gershenwald JE; Andtbacka RH; Prieto VG; Johnson MM; Diwan AH; Lee JE; Mansfield PF; Cormier JN; Schacherer CW; Ross MI
J Clin Oncol; 2008 Sep; 26(26):4296-303. PubMed ID: 18606982
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
Han D; Zager JS; Shyr Y; Chen H; Berry LD; Iyengar S; Djulbegovic M; Weber JL; Marzban SS; Sondak VK; Messina JL; Vetto JT; White RL; Pockaj B; Mozzillo N; Charney KJ; Avisar E; Krouse R; Kashani-Sabet M; Leong SP
J Clin Oncol; 2013 Dec; 31(35):4387-93. PubMed ID: 24190111
[TBL] [Abstract][Full Text] [Related]
28. Prognostic information from sentinel lymph node biopsy in patients with thick melanoma.
Scoggins CR; Bowen AL; Martin RC; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; Hagendoorn L; McMasters KM
Arch Surg; 2010 Jul; 145(7):622-7. PubMed ID: 20644123
[TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node status is the most important prognostic factor for thick (> or = 4 mm) melanomas.
Gutzmer R; Satzger I; Thoms KM; Völker B; Mitteldorf C; Kapp A; Bertsch HP; Kretschmer L
J Dtsch Dermatol Ges; 2008 Mar; 6(3):198-203. PubMed ID: 18093216
[TBL] [Abstract][Full Text] [Related]
30. Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes--one institution's experience.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Melanoma Res; 2003 Feb; 13(1):35-43. PubMed ID: 12569283
[TBL] [Abstract][Full Text] [Related]
31. The predictive value of the sentinel lymph node in malignant melanomas.
Bachter D; Michl C; Büchels H; Vogt H; Balda BR
Recent Results Cancer Res; 2001; 158():129-36. PubMed ID: 11092040
[TBL] [Abstract][Full Text] [Related]
32. Absence of Granzyme B positive tumour-infiltrating lymphocytes in primary melanoma excisional biopsies is strongly associated with the presence of sentinel lymph node metastasis.
van Houdt IS; Sluijter BJ; van Leeuwen PA; Moesbergen LM; Hooijberg E; Meijer CJ; de Gruijl TD; Oudejans JJ; Boven E
Cell Oncol; 2009; 31(5):407-13. PubMed ID: 19759420
[TBL] [Abstract][Full Text] [Related]
33. Presence of Dendritic Cell Subsets in Sentinel Nodes of Breast Cancer Patients Is Related to Nodal Burden.
Szpor J; Streb J; Glajcar A; Sadowski P; Streb-Smoleń A; Jach R; Hodorowicz-Zaniewska D
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955602
[TBL] [Abstract][Full Text] [Related]
34. Small and Isolated Immunohistochemistry-positive Cells in Melanoma Sentinel Lymph Nodes Are Associated With Disease-specific and Recurrence-free Survival Comparable to that of Sentinel Lymph Nodes Negative for Melanoma.
LeBlanc RE; Barton DT; Li Z; Angeles CV; Ernstoff MS; Bagley E; Wimmer D; Wong SL; Barth RJ; Shirai K; Yan S
Am J Surg Pathol; 2019 Jun; 43(6):755-765. PubMed ID: 31091203
[TBL] [Abstract][Full Text] [Related]
35. In-transit intramammary sentinel lymph nodes from malignant melanoma of the trunk.
Lyo V; Jaigirdar AA; Thummala S; Morita ET; Treseler PA; Kashani-Sabet M; Leong SP
Ann Surg; 2012 Jan; 255(1):122-7. PubMed ID: 22143205
[TBL] [Abstract][Full Text] [Related]
36. Sentinel lymph-node biopsy for melanoma of the trunk and extremities: the McGill experience.
Tremblay F; Louffi A; Shibata H; Meterissian S
Can J Surg; 2001 Dec; 44(6):428-31. PubMed ID: 11764875
[TBL] [Abstract][Full Text] [Related]
37. FOXP3 expression and nodal metastasis of breast cancer.
Gökmen-Polar Y; Thorat MA; Sojitra P; Saxena R; Badve S
Cell Oncol (Dordr); 2013 Oct; 36(5):405-9. PubMed ID: 23996727
[TBL] [Abstract][Full Text] [Related]
38. Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up.
Takeshita T; Tsuda H; Moriya T; Yamasaki T; Asakawa H; Ueda S; Sato K; Aida S; Tamai S; Matsubara O; Hase K; Yamamoto J
Ann Surg Oncol; 2012 Apr; 19(4):1160-6. PubMed ID: 21989659
[TBL] [Abstract][Full Text] [Related]
39. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
Rossi CR; De Salvo GL; Bonandini E; Mocellin S; Foletto M; Pasquali S; Pilati P; Lise M; Nitti D; Rizzo E; Montesco MC
Ann Surg Oncol; 2008 Apr; 15(4):1202-10. PubMed ID: 18165880
[TBL] [Abstract][Full Text] [Related]
40. Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer.
Kohrt HE; Nouri N; Nowels K; Johnson D; Holmes S; Lee PP
PLoS Med; 2005 Sep; 2(9):e284. PubMed ID: 16124834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]